| Not Yet Recruiting | Evaluating Efficacy and Safety of Oral Melatonin in Acute Central Serous Chorioretinopathy NCT06809751 | Mohsen Pourazizi | Phase 2 / Phase 3 |
| Not Yet Recruiting | Combination of Micropulse Laser With or Without Photodynamic Therapy for Chronic Central Serous Chorioretinopa NCT06468540 | Beijing Hospital | — |
| Recruiting | the Study of the Association Between the Gut Microbiota and Central Serous Chorioretinopathy NCT06527326 | Second Affiliated Hospital, School of Medicine, Zhejiang University | N/A |
| Recruiting | Central Serous Chorioretinopathy and Micropulse Laser Treatment NCT06346405 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Withdrawn | Navigated Microsecond Laser for Chronic Central Serous Chorioretinopathy: MICROPULSE NCT05679180 | University Hospital, Bordeaux | N/A |
| Terminated | Comfortable and Stabilizing Chin & Forehead Rest Attachment for Slit Lamp Configurations NCT05686421 | NYU Langone Health | N/A |
| Completed | Eplerenone, Aflibercept and Topical Nepafenac Serous Foveal Deta Chment in Central Serous Chorioretinopathy NCT05847049 | Dar El Oyoun Hospital | — |
| Unknown | Two Patterns of Micropulse Laser in the Treatment of Chronic Central Serous Chorioretinopathy NCT05687422 | Beijing Hospital | N/A |
| Recruiting | Subthreshold Nanosecond Laser for Non-resolving Central Serous Chorioretinopathy NCT05570591 | Nova Eye Medical Pty Ltd. | N/A |
| Recruiting | Choroidal Blood Flow in Acute and Chronic Central Serous Chorioretinopathy NCT05589974 | Helse Stavanger HF | — |
| Unknown | Results of Suprachoroidal Steroids Injections in Two Chorioretinal Diseases NCT05337332 | Benha University | Phase 2 / Phase 3 |
| Unknown | Central Serous Chorioretinopathy Registry and Pachychoroid Observation and Natural History Study NCT05278169 | Chinese University of Hong Kong | — |
| Unknown | Pilot Study on Deep Learning in the Eye NCT04665102 | CRG UZ Brussel | — |
| Completed | Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus Photograph NCT04723160 | Visionary Intelligence Ltd. | — |
| Unknown | Panmacular Versus Minimal Micropulse Laser Therapy in Central Serous Chorioretinopathy NCT04410861 | Moorfields Eye Hospital Centre Abu Dhabi | N/A |
| Unknown | Different Doses of vPDT in the Treatment of cCSC NCT05390619 | Peking University People's Hospital | N/A |
| Unknown | PRedictive Factors and Changes From Treatment in iPCV Versus CSR Versus nAMD With afLibercept NCT02681783 | Sunnybrook Health Sciences Centre | Phase 4 |
| Completed | Treatment of Chronic Central Serous Chorioretinopathy Via Electromagnetic Stimulation and Platelet- Rich Plasm NCT04224831 | Ankara Universitesi Teknokent | N/A |
| Unknown | Brinzolamide for the Treatment of Chronic Central Serous Chorioretinopathy NCT03542006 | Tel-Aviv Sourasky Medical Center | Phase 2 |
| Completed | Effects of OCTA-guided PDT in Acute CSC NCT03497000 | Peking University People's Hospital | N/A |
| Completed | Selective Retina Therapy With Real-Time Feedback-Controlled Dosimetry for Treating Acute Idiopathic Central Se NCT03339856 | Kim's Eye Hospital | N/A |
| Unknown | The Changes of Retinal Capillaries After Half-dose PDT Measured by OCTA in Eyes With CSC NCT03692169 | Jin Chen-jin | — |
| Completed | Optical Coherence Tomography Angiography (OCT-A) and Central Serous Chorioretinopathy (CSC) NCT03950089 | Hospices Civils de Lyon | — |
| Unknown | Angiographic Characteristics of CSC, PCV Patients and Thrombotic Bio-markers NCT02815176 | Samsung Medical Center | — |
| Terminated | Multimodal Imaging in Central Serous Chorioretinopathy NCT02889185 | Centre Hospitalier Universitaire de Besancon | N/A |
| Completed | Selective Retina Therapy With 'R:GEN' in Patients With Central Serous Chorioretinopathy NCT03758963 | CynosureLutronic | N/A |
| Completed | Eplerenone Versus PDT: Comparative Study by OCTA NCT05104138 | Federico II University | — |
| Completed | Short-Term Oral Mifepristone for Central Serous Chorioretinopathy NCT02354170 | Roger Goldberg, M.D., MBA | Phase 2 |
| Unknown | A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy NCT02215330 | Prim. Prof. Dr. Oliver Findl, MBA | Phase 2 / Phase 3 |
| Recruiting | OCT in Rare Chorioretinal Diseases NCT02141308 | Oregon Health and Science University | — |
| Unknown | Eplerenone For the Treatment of Chronic Central Serous Chorioretinopathy NCT02153125 | Tel-Aviv Sourasky Medical Center | Phase 2 |
| Completed | Eplerenone for the Treatment of Central Serous Chorioretinopathy NCT01990677 | Wills Eye | N/A |
| Completed | Efficacy and Safety of Intravitreal Aflibercept Injection for Subacute Central Serous Chorioretinopathy NCT01971190 | Asan Medical Center | Phase 2 |
| Completed | Eplerenone for Central Serous Chorioretinopathy NCT01822561 | Tufts Medical Center | Phase 2 |
| Terminated | Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy NCT01982383 | George Washington University | N/A |
| Completed | Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD NCT01880788 | Sequenom, Inc. | — |
| Completed | The Safety & Efficacy of Intravitreal Aflibercept Injection in Patients With Persistent Central Serous Chorior NCT01710332 | Wills Eye | Phase 2 |
| Unknown | Methotrexate for Central Serous Chorioretinopathy Treatment Trial NCT01633983 | Edward Averbukh | Phase 2 |
| Unknown | The Safe Effective Light Dose of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy NCT01630863 | Yeungnam University College of Medicine | N/A |
| Completed | Central Serous Chorioretinopathy: Etiology, Course and Prognosis NCT01378130 | Medical University of Vienna | — |
| Completed | Study of Photodynamic Therapy (PDT) in Patients With Central Serous Chorioretinopathy (CSC) NCT01574430 | Peking University People's Hospital | Phase 4 |
| Terminated | Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina NCT02088151 | Insel Gruppe AG, University Hospital Bern | N/A |
| Unknown | The Effect of Therapy With Bevacizumab in Chronic Central Serous Chorioretinopathy NCT00864773 | Hallym University Medical Center | N/A |
| Completed | Central Serous Chorioretinopathy Treated by Modified Photodynamic Therapy NCT01019668 | Shin Kong Wu Ho-Su Memorial Hospital | N/A |
| Completed | Micropulse Diode Laser Treatment for Chronic Central Serous Chorioretinopathy NCT01327170 | Federal University of São Paulo | N/A |
| Completed | Effect of Helicobacter Pylori Treatment on Idiopathic Central Serous Chorioretinopathy (ICSCR) NCT00817245 | Tabriz University | Phase 1 / Phase 2 |
| Completed | Comparison of Multifocal Electroretinogram Assessment in Chronic Central Serous Chorioretinopathy (CSC) Betwee NCT00803517 | Samsung Medical Center | — |
| Completed | Bevacizumab Versus Micropulse in Central Serous Chorioretinopathy (CSC) NCT00802906 | Johann Wolfgang Goethe University Hospital | N/A |
| Completed | Selective Retina Therapy (SRT) in Patients With Idiopathic Central Serous Retinopathy NCT00987077 | University of Kiel | Phase 2 |
| Completed | Intravitreal Ranibizumab Treatment of Central Serous Chorioretinopathy NCT00403325 | Vitreous -Retina- Macula Consultants of New York | Phase 1 |
| Withdrawn | Intravitreal Bevacizumab for the Treatment of Central Serous Chorioretinopathy NCT00418431 | Asociación para Evitar la Ceguera en México | Phase 2 / Phase 3 |
| Completed | High-dose Antioxidants for Central Serous Chorioretinopathy NCT00963131 | Prince of Songkla University | Phase 2 |
| Unknown | Selective RPE Laser Treatment (SRT) for Various Macular Diseases NCT00403884 | University of Regensburg | N/A |